早期中轴型脊柱关节炎与非中轴型脊柱关节炎慢性背痛患者基线及2年时脊柱症状与脊柱和髋关节活动度的差异
基于SPondyloarthritis Caught Early队列,比较294例早期中轴型脊柱关节炎(axSpA)与123例非axSpA慢性背痛患者基线和2年时的脊柱症状及脊柱/髋关节活动度。基线时非axSpA患者症状和活动度更差(除枕墙距外);2年时两组所有症状和颈椎旋转均显著改善,但腰椎侧屈和改良Schober试验仅axSpA组改善。多变量分析显示axSpA与夜间背痛、改良Schober试验、踝间距和BASMI更大改善相关,但枕墙距正常可能性更低。
要点
- 基线时非axSpA患者症状和活动度更差,但枕墙距axSpA组更差。
- 2年时两组脊柱症状和颈椎旋转均显著改善,但腰椎侧屈和改良Schober仅axSpA组改善。
- axSpA与夜间背痛、改良Schober、踝间距和BASMI更大改善相关,但与枕墙距正常可能性更低相关。
核心结论
- 2年内两组所有脊柱症状和部分活动度指标均改善,但功能障碍仍普遍存在(尤其非axSpA组);axSpA与夜间背痛、改良Schober试验、踝间距和BASMI更大改善相关,但与枕墙距受损更严重相关。
研究设计与样本
- 分析SPondyloarthritis Caught Early队列的基线和2年数据,纳入294例axSpA和123例非axSpA慢性背痛患者(平均症状持续时间13个月)。
- 采用线性回归或零膨胀负二项回归比较两组2年结局,校正基线值、性别、年龄和非甾体抗炎药使用。
主要发现
- 基线时非axSpA患者症状和活动度更差,但枕墙距除外:夜间背痛均值(标准差)axSpA组3.6(2.9)vs 非axSpA组4.6(2.7);枕墙距0.5(1.2)vs 0.1(0.7)。
- 2年后两组所有症状和颈椎旋转均显著改善,但腰椎侧屈和改良Schober试验仅在axSpA组显著改善。
- 多变量分析中,axSpA与夜间背痛更大改善相关(β(95%CI):-0.85(-1.47;-0.23)),与改良Schober试验更大改善相关(0.26(0.03;0.50)),与踝间距更大改善相关(4.86(1.93;7.80)),与BASMI更大改善相关(-0.24(-0.41;-0.08))。
- axSpA与枕墙距正常的可能性更低相关(OR(95%CI):0.09(0.01;0.83))。
关键数值与推荐
- 原文未报告推荐条款或关键阈值。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare spinal symptoms and spinal/hip mobility at baseline and 2 years in early axial spondyloarthritis (axSpA) and non-axSpA chronic back pain (BP) patients. METHODS: Baseline and 2 years data of the SPondyloarthritis Caught Early cohort were analysed. Outcomes assessed: overall BP, BP at night, morning stiffness (MS) intensity, MS duration, occiput-to-wall distance (OWD), cervical rotation, chest expansion, lateral spinal flexion (LSF), modified Schober test (mSchober), intermalleolar distance (IMD) and Bath Ankylosing Spondylitis Metrology Index (BASMI). Linear or zero-inflated negative binomial regression was used to compare 2 years outcomes between groups (adjusting for baseline value, sex, age and use of non-steroidal anti-inflammatory drugs). RESULTS: There were 294 axSpA and 123 non-axSpA patients (mean symptom duration: 13 months). At baseline, non-axSpA patients had worse symptoms and mobility, except OWD (eg, mean(SD): BP at night 3.6 (2.9) axSpA vs 4.6 (2.7) non-axSpA; OWD 0.5 (1.2) vs 0.1 (0.7)). After 2 years, all symptoms and cervical rotation significantly improved in both groups, but LSF and mSchober only in axSpA. In multivariable analyses, axSpA was associated with larger improvements in BP at night (β (95% CI): -0.85 (-1.47; -0.23)), mSchober (0.26 (0.03; 0.50)), IMD (4.86 (1.93; 7.80)) and BASMI (-0.24 (-0.41; -0.08)), and with lower likelihood of a normal OWD (OR (95% CI): 0.09 (0.01; 0.83)). CONCLUSION: Over 2 years, all spinal symptoms and some mobility measures improved in both groups, but impairments remained prevalent (particularly in non-axSpA). Nevertheless, axSpA was associated with larger improvements in BP at night, mSchober, IMD and BASMI, but with more OWD impairment.
引用
- Bento da Silva A, Ramiro S, van Lunteren M, et al. Baseline and 2-year differences in spinal symptoms and spinal and hip mobility in early axial spondyloarthritis and non-axial spondyloarthritis chronic back pain patients. RMD Open. 2024. PMID: 39461873. doi:10.1136/rmdopen-2024-004713
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。